日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Talimogene laherparepvec and atezolizumab in HER2-negative breast cancer following neoadjuvant chemotherapy: a window-of-opportunity phase II trial (SOLTI-1503 PROMETEO)

Talimogene laherparepvec 和 atezolizumab 在新辅助化疗后 HER2 阴性乳腺癌中的应用:一项机会窗口 II 期试验 (SOLTI-1503 PROMETEO)

Pascual, Tomás; Vidal, Maria; Cejalvo, Juan M; Vega, Estela; Sanfeliu, Esther; Villacampa, Guillermo; Ganau, Sergi; Parreño, Ana María Julve; Zamora, Esther; Miranda, Ignacio; Delgado, Ana; Bermejo, Begoña; Seguí, Elia; Brasó-Maristanty, Fara; de la Cruz-Merino, Luis; Juan, Manel; Galván, Patricia; Gonzàlez-Farré, Xavier; Chillara, Samyukta; Villagrasa, Patricia; Pfefferle, Adam D; O'Connell, Constandina E; Ferrero-Cafiero, Juan M; Oliveira, Mafalda; Perou, Charles M; Prat, Aleix

BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203

BO-112联合帕博利珠单抗治疗抗PD-1耐药晚期黑色素瘤患者:II期临床试验SPOTLIGHT-203

Márquez-Rodas, Iván; Dutriaux, Caroline; Saiag, Philippe; de la Cruz Merino, Luis; Castañón Álvarez, Eduardo; Robert, Caroline; Rodríguez-Moreno, Juan F; Arance, Ana; Cerezuela-Fuentes, Pablo; Montaudié, Henri; Sanmamed, Miguel F; González-Cao, María; Charles, Julie; López Criado, María Pilar; Berrocal, Alfonso; de Miguel, Enrique; Funck-Brentano, Elisa; Prey, Sorilla; Álamo de la Gala, Mᵃ Carmen; Melero, Ignacio; Avilés-Izquierdo, Jose Antonio; Roman, Ruth; Garcia-Pelaez, Beatriz; Rodriguez, Sonia; Trnkova, Zuzana Jirakova; Quintero, Marisol; Maciá, Sonia; Chaney, Marya F; Dalle, Stephane

Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecific

替贝他福司(一种T细胞受体-CD3双特异性抗体)治疗期间肿瘤免疫图谱的演变

Joseph J Sacco,Peter Kirk,Emma Leach,Alexander N Shoushtari,Richard D Carvajal,Camille Britton-Rivet,Sophie Khakoo,Laura Collins,Luis de la Cruz-Merino,Zeynep Eroglu,Alexandra P Ikeguchi,Paul Nathan,Omid Hamid,Marcus O Butler,Sarah Stanhope,Koustubh Ranade,Takami Sato

Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study

tiragolumab、atezolizumab 和化疗治疗早期或 PD-L1 阳性晚期三阴性乳腺癌的安全性和有效性:一项 Ib 期研究

Kuemmel, S; Jung, K H; Andrade, L; Assad-Suzuki, D; de la Cruz Merino, L; Freitas-Junior, R; Hegg, R; Huang, C-S; Martin, H; Schneeweiss, A; Dieterich, M; Nguyen Duc, A; Feng, Y; Meng, R; Swat, A; Seiller, A; Bermejo, B; Hamilton, E P

Management of immune-related myocarditis, myositis and myasthenia gravis (MMM) overlap syndrome: a single institution case series and literature review

免疫相关性心肌炎、肌炎和重症肌无力(MMM)重叠综合征的管理:单中心病例系列及文献综述

Sánchez-Camacho, Alberto; Torres-Zurita, Alberto; Gallego-López, Laura; Hernández-Pacheco, Rocío; Silva-Romeiro, Silvia; Álamo de la Gala, María Del Carmen; Peral-Gutiérrez de Ceballos, Enrique; de la Cruz-Merino, Luis

Role of Sam68 in different types of cancer (Review)

Sam68在不同类型癌症中的作用(综述)

Jiménez-Cortegana, Carlos; Sánchez-Jiménez, Flora; De La Cruz-Merino, Luis; Sánchez-Margalet, Víctor

Obesity and overweight in R/R DLBCL patients is associated with a better response to treatment of R2-GDP-GOTEL trial. Potential role of NK CD8 + cells and vitamin D

在复发/难治性弥漫性大B细胞淋巴瘤(R/R DLBCL)患者中,肥胖和超重与R2-GDP-GOTEL试验中更好的治疗反应相关。NK CD8+细胞和维生素D的潜在作用

Hontecillas-Prieto, Lourdes; García-Domínguez, Daniel J; Jiménez-Cortegana, Carlos; Nogales-Fernández, Esteban; Palazón-Carrión, Natalia; García-Sancho, Alejandro Martín; Ríos-Herranz, Eduardo; Gumà-Padrò, Josep; Provencio-Pulla, Mariano; Rueda-Domínguez, Antonio; de la Cruz-Merino, Luis; Sánchez-Margalet, Víctor

Administration of nivolumab plus ipilimumab: Infusion of the fixed-ratio combination versus sequential infusions in two randomized controlled trials of metastatic melanoma (CheckMate 742) and renal cell carcinoma (CheckMate 800)

纳武利尤单抗联合伊匹木单抗的给药:在两项转移性黑色素瘤(CheckMate 742)和肾细胞癌(CheckMate 800)的随机对照试验中,比较固定比例组合输注与序贯输注的效果

Menzies, Alexander M; Salman, Pamela; Frontera, Osvaldo Arén; Pook, David; Hocking, Christopher M; Zakharia, Yousef; Gurney, Howard; Gedye, Craig; Goh, Jeffrey C; Telivala, Bijoy; Grob, Jean-Jacques; Lebbé, Céleste; de la Cruz Merino, Luis; Machet, Laurent; Neidhardt, Eve-Marie; Qureshi, Anila; Hosein, Fareeda; Hamuro, Lora; Simsek, Burcin; Amin, Asim

Emerging Role of MDSCS as Novel Biomarkers and Therapeutic Targets for Cancer Immunotherapy

MDSC作为新型生物标志物和癌症免疫治疗靶点的新兴作用

Silva-Romeiro, S; Flores-Campos, Rocio Del Carmen; Sánchez-León, María Luisa; Sánchez-Margalet, V; De la Cruz-Merino, Luis

Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial

酮体是复发/难治性弥漫性大B细胞淋巴瘤的潜在预后生物标志物:R2-GDP-GOTEL试验结果

Fernández-Castillejo, Sara; Badia, Joan; de la Cruz-Merino, Luís; Martín Garcia-Sáncho, Alejandro; Carnicero-González, Fernando; Palazón-Carrión, Natalia; Ríos-Herranz, Eduardo; de la Cruz-Vicente, Fátima; Rueda-Domínguez, Antonio; Martínez-Banaclocha, Natividad; Gómez-Codina, José; Labrador, Jorge; Martínez-Madueño, Francisca; Amigó, Núria; Salar-Silvestre, Antonio; Rodríguez-Abreu, Delvys; Gálvez-Carvajal, Laura; Sánchez-Beato, Margarita; Provencio-Pulla, Mariano; Guirado-Risueño, Maria; Nogales, Esteban; Sánchez-Margalet, Víctor; Jiménez-Cortegana, Carlos; Rodríguez-García, Guillermo; Cumeras, Raquel; Gumà, Josep